DiscGenics treates First Patients in Japanese Clinical Trial of Cell Therapy for DDD
Clinical Research | News | 0 Comment | 08 Aug, 2019
DiscGenics, Inc., a US based clinical-stage biotechnology company focused on developing regenerative cell-based therapie...Read more
SillaJen to discontinue PHOCUS trial for advanced liver cancer
Clinical Research | News | 0 Comment | 06 Aug, 2019
SillaJen, Inc., a South Korea based clinical-stage, biotherapeutics company focused on the development of oncolytic immu...Read more
"Improving trial efficiency and lowering trial costs is a big challenge"
Clinical Research | Opinion | 2 Comment | 05 Aug, 2019
Historically, getting patients in clinical trials is the biggest challenge to healthcare breakthrough. But now data can ...Read more
Botanix receives commitments for A$40M in US-led institutional placement
Clinical Research | News | 0 Comment | 05 Aug, 2019
Australia headquartered Clinical stage cannabinoid company Botanix Pharmaceuticals has announced the receipt of firm com...Read more
Veristat expands operations into Taiwan
Clinical Research | News | 0 Comment | 01 Aug, 2019
US headquartered Veristat, a scientifically oriented clinical development, and regulatory submission partner, announces ...Read more
CStone to initiate ivosidenib Phase I study in China
Clinical Research | News | 0 Comment | 22 Jul, 2019
CStone Pharmaceuticals has received approval from China National Medical Products Administration (NMPA) to initiate a Ph...Read more
Kazia to use drug with radiotherapy for brain cancer treatment
Clinical Research | News | 0 Comment | 23 Jul, 2019
Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, is pleased to announce that Memorial S...Read more
SOTIO initiates first-in-human clinical trial with IL-15 superagonist SO-C101
Clinical Research | News | 0 Comment | 12 Jul, 2019
SOTIO and Cytune Pharma, members of the PPF Group have announced that the first dosing of cancer patients with ...Read more
CStone announces first patient dosed in China with avapritinib for advanced GIST
Clinical Research | News | 0 Comment | 10 Jul, 2019
CStone Pharmaceuticals, on 9 July 2019, announced in Suzhou, China that the first patient has been dosed in Ch...Read more
Clinical Research | News | 0 Comment | 08 Jul, 2019
Sangamo Therapeutics, a genomic medicine company, and Pfizer has announced updated results from the Phase 1/2 ...Read more
Takeda announces results from Phase IIIb/IV clinical trial for ADYNOVATE
Clinical Research | News | 0 Comment | 08 Jul, 2019
Takeda, an R&D-driven, global biopharmaceutical company with a leadership position in rare diseases has announced up...Read more
Sommetrics completes study of new sleep apnea treatment in ethnic Japanese subjects
Clinical Research | News | 0 Comment | 26 Jun, 2019
Sommetrics, a company dedicated to developing state of the art products to treat obstructive sleep apnea (OSA) has annou...Read more
FDA Grants Orphan Drug Designation to XWL-008 to treat Narcolepsy
Clinical Research | News | 0 Comment | 25 Jun, 2019
XW Laboratories Inc., a China headquartered clinical-stage biopharmaceutical company pioneering the discovery of novel s...Read more
Prestige Biopharma reports Ph III results for Tuznue
Clinical Research | News | 0 Comment | 24 Jun, 2019
Prestige BioPharma has announced positive top-line results from a Phase III global clinical trial (Troika) evaluati...Read more
Parexel launches an enhanced integrated outsourcing delivery model for FSP
Clinical Research | News | 0 Comment | 24 Jun, 2019
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to marke...Read more
Asieris Completes Enrolment for US APL-1202 Phase Ib Clinical Trial
Clinical Research | News | 0 Comment | 24 Jun, 2019
Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the t...Read more
FasT CAR-19 Therapy Shows Positive Impact in Patients with (r/r) B-ALL
Clinical Research | News | 0 Comment | 21 Jun, 2019
Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage cellular immunotherapy company, on 21 June 2019, announc...Read more
Edesa Biotech receives approval to proceed with its clinical investigation
Clinical Research | News | 0 Comment | 20 Jun, 2019
Edesa Biotech, a clinical-stage biopharmaceutical company has reported that the U.S. Food and Drug Administration h...Read more